Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





2025 ADLM Disruptive Technology Award Finalists Showcase Breakthrough Diagnostic Tools and Technologies

By LabMedica International staff writers
Posted on 24 Jul 2025

The finalists for this year’s ADLM Disruptive Technology Award Competition will present at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) on July 28. More...

Now in its eighth year, the competition recognizes innovative testing and disruptive technology solutions with the potential to improve diagnostic performance or access to high-quality patient care. Through the competition, ADLM welcomes applications from companies developing new, disruptive diagnostic tools and/or technologies. ADLM seeks technologies that are unknown to the laboratory medicine community, in the hope that the competition can help companies take the next step in development for the benefit of medical professionals and the patients who rely on them. Not only does the Disruptive Technology Award Competition recognize breakthrough technologies, but it also gives the diagnostic and laboratory medicine community an early look at innovative and impactful products that address gaps in the field and/or improve upon existing solutions.

The finalists for this year’s ADLM Disruptive Technology Award Competition are making breakthroughs aimed at detecting heart attacks in minutes, reducing pathogen and antimicrobial susceptibility, and enabling advanced molecular diagnostics without added costs. In May, three finalists were chosen from six semifinalists. They include Chemeleon which has been chosen for its binding-induced nanostructure dynamic surface (BINDS) assay, a first-of-its kind, instrument-free diagnostic platform that delivers lab-precision results in under 2 minutes. Their lead product targets acute myocardial infarction by detecting and quantifying cardiac troponins with 99.2% sensitivity and 90.5% specificity. The second finalist, MagicIC Lifescience, has been for its MagChipR, a point-of-care molecular diagnostic testing platform. This affordable, ultra-fast PCR system with high multiplexing capability can deliver lab-quality pathogen and antimicrobial susceptibility results in under 20 minutes. This means same-visit results, diagnosis, and treatment, leading to better patient outcomes and lower costs.

The third finalist, Rarity Bioscience, has been chosen for its Rarity superRCA, an ultrasensitive molecular amplification technology that converts nucleic acid sequences into fluorescent particles. This technology allows molecular analysis via standard flow cytometry, which is already widely available in hematology and pathology labs. By leveraging existing infrastructure, superRCA enables the seamless adoption of advanced molecular diagnostics without additional capital investment. The ADLM Disruptive Technology Award Competition also includes semifinalists who are not eligible for the top prize, but continue to make great strides in laboratory medicine.

For instance, Bloodscan Biotech’s Labyrinth One product is an automated circulating tumor cell (CTC) enrichment system that enables high-throughput, label-free isolation of viable CTCs from blood samples. The disruption is its speed: Labyrinth One provides rapid, high-purity CTC enrichment in just 15 minutes. Similarly, C2N Diagnostics’ PrecivityAD2 blood test is changing how medical professionals identify the presence or absence of brain amyloid pathology in people with cognitive impairment. It’s simpler, less burdensome, and less expensive than tests that use cerebrospinal fluid or brain amyloid PET imaging. Also, Truvian’s TruAnalyzer is a multi-modal platform capable of simultaneously performing clinical chemistry, immunoassay, and hematology tests with less than 10 drops of whole blood. The goal is to make routine blood testing simple and more convenient. All six finalists and semifinalists will showcase their technologies from July 29–31 at the ADLM Clinical Lab Expo. The winner will be announced at the end of the session.

Related Links:
ADLM


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Portable Electronic Pipette
Mini 96
ESR Analyzer
TEST1 2.0
New
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.